Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.37 |
| ▸ | MMP12 | P39900 | 2/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | FABP7 | O15540 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18681694 | 1.00 | NAAA (0.58) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| SCHEMBL15727148 | 1.00 | NAAA (0.58) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| SCHEMBL24530568 | 0.89 | — | — | |
| SCHEMBL8726974 | 0.88 | NAAA (0.64) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| SCHEMBL781576 | 0.87 | NAAA (0.46) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| SCHEMBL31069913 | 0.87 | NAAA (0.66) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| SCHEMBL258780 | 0.87 | NAAA (0.66) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| SCHEMBL7568980 | 0.87 | NAAA (0.66) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| Hydrochloric Acid SCHEMBL8726966 | 0.86 | NAAA (0.62) | NAAACYP2C19HTTCYP19A1EPHX1 | |
| SCHEMBL8104397 | 0.85 | NAAA (0.70) | NAAACYP2C19HTTCYP19A1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117551039-A | Aryl formamide compound, preparation method thereof and application of aryl formamide compound in resisting enterovirus EV71 | 武汉大学 | 2024-02-13 | — | — | CN | claimed |
| CN-1325378-A | Process for the synthesis of 1-(aminomethyl) cyclohexyl-acetic acid | RICHTER GEDEON VEGY ZETI GY & (HU) | 2001-12-05 | — | — | CN | claimed |
| CN-113735700-B | Synthesis process of gabapentin intermediate | 扬州工业职业技术学院 | 2023-07-28 | — | — | CN | disclosed |
| WO-2022129041-A1 | PRODRUGS OF 3-BENZOAMIDO-2-AMINOPROPIONIC ACID DERIVATIVES AS MODULATORS OF THE NMDA RECEPTOR | H. LUNDBECK A/S (DK) | 2022-06-23 | — | — | WO | disclosed |
| CN-114645027-A | Aminotransferase mutant from bacillus megatherium and application thereof | 上海合全药物研发有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-113735700-A | Synthesis process of gabapentin intermediate | 扬州工业职业技术学院 | 2021-12-03 | — | — | CN | disclosed |
| WO-2021001420-A1 | PRODRUGS OF MODULATORS OF THE NMDA RECEPTOR | H. LUNDBECK A/S (DK) | 2021-01-07 | — | — | WO | disclosed |
| WO-2018141796-A1 | NOVEL METHODS FOR SUB-TYPING AND TREATING CANCER | HI-STEM GGMBH (DE) | 2018-08-09 | — | — | WO | disclosed |
| US-9309285-B2 | Macrocyclic broad spectrum antibiotics | RQX PHARMACEUTICALS, INC. (US) | 2016-04-12 | — | — | US | disclosed |
| CN-105440032-A | PYRAZINE DERIVATIVES AS ENAC BLOCKERS | NOVARTIS AG | 2016-03-30 | — | — | CN | disclosed |
| CN-103249723-B | Pyrazine derivatives as ENAC blockers | NOVARTIS AG (CH) | 2015-11-25 | — | — | CN | disclosed |
| EP-0711760-B1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL IND LTD (JP) | 2002-05-15 | — | — | EP | disclosed |
| WO-2000032167-A9 | A POLYSOME | SDG INC (US) | 2001-12-13 | — | — | WO | disclosed |
| US-6130332-A | USING A GROUP 8 METAL CATALYST AND ALDEHYDES OR KETONE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-10 | — | — | US | disclosed |
| WO-2000032167-A1 | A POLYSOME | SDG, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0969823-A2 | ANTI-EPILEPTOGENIC AGENTS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998040055-A2 | ANTI-EPILEPTOGENIC AGENTS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1998-09-17 | — | — | WO | disclosed |
| US-5792867-A | Method of alkylating of triazine derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0760369-A1 | PROCESS FOR ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1997-03-05 | — | — | EP | disclosed |
| EP-0711760-A1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |